Danila Valmori
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 14, 2021
Modulation of Cytokine Secretion Allows CD4 T Cells Secreting IL-10 and IL-17 to Simultaneously Participate in Maintaining Tolerance and Immunity.
Journal: PloS one
Published: August 25, 2015
Consensus nomenclature for CD8+ T cell phenotypes in cancer.
Journal: Oncoimmunology
Published: December 09, 2014
Comment on "differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors".
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 21, 2014
Differential expression of the immunosuppressive enzyme IL4I1 in human induced Aiolos+, but not natural Helios+, FOXP3+ Treg cells.
Journal: European journal of immunology
Published: June 02, 2014
Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathologic features and mutational status of EGFR and KRAS.
Journal: Cancer immunology research
Published: May 29, 2014
CD4+ T effectors specific for the tumor antigen NY-ESO-1 are highly enriched at ovarian cancer sites and coexist with, but are distinct from, tumor-associated Treg.
Journal: Cancer immunology research
Published: April 30, 2014
Expression of MAGE-A3/6 in primary breast cancer is associated with hormone receptor negative status, high histologic grade, and poor survival.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: February 11, 2014
Last Updated: 09/26/2026